spermidine has been researched along with Insulin Resistance in 4 studies
Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Spermidine serves as an oral supplement to attenuate obesity and metabolic disorders through hypothalamus-dependent or -independent BAT activation and skeletal muscle adaptation." | 8.02 | Oral Spermidine Targets Brown Fat and Skeletal Muscle to Mitigate Diet-Induced Obesity and Metabolic Disorders. ( Guo, C; Jia, Y; Jie, H; Li, R; Li, Y; Mao, H; Tao, Y; Wang, D; Wang, Q; Yin, J; Zhang, L; Zhao, J; Zhou, Z; Zhu, F, 2021) |
| "Background: Although animal experiments have shown that spermidine (SPD) affects insulin resistance (IR), the evidence for this in humans is still scarce." | 4.12 | Association between Serum Spermidine and TyG Index: Results from a Cross-Sectional Study. ( Feng, W; Gao, H; Gu, C; Li, R; Sun, Z; Xu, J; Yu, Z; Yuan, W; Zhang, R; Zheng, L, 2022) |
| "Spermidine serves as an oral supplement to attenuate obesity and metabolic disorders through hypothalamus-dependent or -independent BAT activation and skeletal muscle adaptation." | 4.02 | Oral Spermidine Targets Brown Fat and Skeletal Muscle to Mitigate Diet-Induced Obesity and Metabolic Disorders. ( Guo, C; Jia, Y; Jie, H; Li, R; Li, Y; Mao, H; Tao, Y; Wang, D; Wang, Q; Yin, J; Zhang, L; Zhao, J; Zhou, Z; Zhu, F, 2021) |
| "Type 2 diabetes is characterized by hyperglycemia derived from insulin resistance in periphery tissue." | 1.48 | Enhancement of Glucose Utilization by Loesenerine through AMPK Activation in Myotubes. ( Jiang, HW; Li, JL; Li, JY; Wang, LN, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, R | 1 |
| Xu, J | 1 |
| Li, R | 2 |
| Yu, Z | 1 |
| Yuan, W | 1 |
| Gao, H | 1 |
| Feng, W | 1 |
| Gu, C | 1 |
| Sun, Z | 1 |
| Zheng, L | 1 |
| Sasaki, GY | 1 |
| Li, J | 1 |
| Cichon, MJ | 1 |
| Kopec, RE | 1 |
| Bruno, RS | 1 |
| Wang, D | 1 |
| Yin, J | 1 |
| Zhou, Z | 1 |
| Tao, Y | 1 |
| Jia, Y | 1 |
| Jie, H | 1 |
| Zhao, J | 1 |
| Li, Y | 1 |
| Guo, C | 1 |
| Zhu, F | 1 |
| Mao, H | 1 |
| Zhang, L | 1 |
| Wang, Q | 1 |
| Wang, LN | 1 |
| Jiang, HW | 1 |
| Li, JL | 1 |
| Li, JY | 1 |
4 other studies available for spermidine and Insulin Resistance
| Article | Year |
|---|---|
Association between Serum Spermidine and TyG Index: Results from a Cross-Sectional Study.
Topics: Adult; Biomarkers; Blood Glucose; Cross-Sectional Studies; Electrolytes; Glucose; Humans; Insulin Re | 2022 |
Catechin-Rich Green Tea Extract and the Loss-of-TLR4 Signaling Differentially Alter the Hepatic Metabolome in Mice with Nonalcoholic Steatohepatitis.
Topics: Acetyl Coenzyme A; Animals; Arginine; Bile Acids and Salts; Catechin; Dietary Supplements; Genotype; | 2021 |
Oral Spermidine Targets Brown Fat and Skeletal Muscle to Mitigate Diet-Induced Obesity and Metabolic Disorders.
Topics: Adipose Tissue, Brown; Administration, Oral; Animals; Diet, High-Fat; Hypothalamus; Insulin Resistan | 2021 |
Enhancement of Glucose Utilization by Loesenerine through AMPK Activation in Myotubes.
Topics: Alkaloids; AMP-Activated Protein Kinases; Animals; Cell Line; Diabetes Mellitus, Type 2; Enzyme Acti | 2018 |